Partnership between MP Govt and Haleon marks the beginning of a new chapter of limitless possibilities, says CM Mohan Yadav
Madhya Pradesh CM Dr. Mohan Yadav has said that India has established itself as the ‘Pharmacy of the World’. Today, the world views India not merely as a large market, but also as a trusted manufacturing destination, a reliable global supply chain partner and an emerging economic powerhouse. He stated that Madhya Pradesh is playing an increasingly significant role in India's journey towards becoming a global pharma hub. The state is entering a new era of investment, driving unprecedented economic and industrial growth.
Chief Minister Dr. Yadav noted that Haleon has chosen Pithampur in Madhya Pradesh to set up its first manufacturing facility in India. He described Madhya Pradesh as a land of opportunities and success, adding that the partnership between the State Government and Haleon marks the beginning of a new chapter of mutual trust and limitless possibilities.
CM emphasised that the confidence reposed by industries and investors from across India and the world in Madhya Pradesh stems from its industry-friendly policies, and that this trust is the state's greatest asset.
CM addressed and performed Bhoomi Poojan virtually for Haleon Group’s first manufacturing unit in Pithampur on Monday. He performed the Bhoomi Poojan of the new unit by pressing a remote button symbolically.
CM Mohan Yadav said that Madhya Pradesh is transforming into a self-reliant and future-ready state. He assured that all investors seeking to establish industries in the state would receive full support from the government at every stage, from project establishment to commencement of production.
Haleon manufacturing facility will generate employment opportunities
It was informed that the Haleon manufacturing facility will generate direct and indirect employment opportunities for nearly 1,000 people. Appreciating the company’s commitment to providing up to 30 per cent employment opportunities to women, the Chief Minister said that this initiative would further strengthen the State Government’s efforts towards women’s empowerment.
CM assured Haleon of the government’s continued support
CM Mohan Yadav, congratulating Haleon Group on the historic occasion, assured the company of the government’s continued support. He noted that the company has initially invested Rs 2,000 crore in Madhya Pradesh and expressed confidence that, through collective efforts, this investment could eventually grow from Rs 2,000 crore to Rs 2 lakh crore. CM also extended a warm invitation to Haleon and other investors to invest in Madhya Pradesh without hesitation.
CM felicitated Haleon CEO Brian McNamara with a traditional angavastram and memento. McNamara also presented a souvenir to the Chief Minister and expressed gratitude for the support extended by the Government of Madhya Pradesh.
Chief Minister Dr. Yadav highlighted that India is the world’s third-largest producer of pharmaceuticals by volume, with more than 3,000 pharmaceutical companies and over 10,500 manufacturing units operating across the country.
Company’s first manufacturing facility in India: McNamara
Speaking on the occasion, Haleon Group CEO Brian McNamara said that this would be the company’s first manufacturing facility in India and expressed delight at establishing operations in Madhya Pradesh. He described India as one of the world’s fastest-growing economies and Madhya Pradesh as one of its most rapidly emerging states.
McNamara stated that the facility represents the on-ground implementation of Haleon’s India vision. The CEO stated that the company has currently invested £175 million in Madhya Pradesh and plans to further expand its operations in Pithampur, which serves as Central India’s logistics hub.
Haleon and the New Manufacturing Facility in Pithampur
Haleon is one of the world’s leading consumer healthcare companies, with operations in more than 170 countries. The company manufactures products in categories such as oral health, digestive health, pain relief and respiratory care (PRS), as well as vitamins, minerals and supplements.
The state-of-the-art manufacturing facility, being developed across more than 40 acres in the Smart Industrial Park at Pithampur, will primarily manufacture oral healthcare products. Products manufactured at the facility will cater not only to domestic demand in India but will also be exported to markets across the Asia-Pacific region, the Middle East and Africa.
The project is expected to create significant opportunities for local MSMEs, supplier networks, transportation services, logistics providers, and other ancillary industries, thereby contributing substantially to the region’s industrial ecosystem and economic growth.